RPg Family Wealth Advisory LLC purchased a new stake in shares of Tenet Healthcare Co. (NYSE:THC – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 53,456 shares of the company’s stock, valued at approximately $8,884,000. Tenet Healthcare comprises about 2.5% of RPg Family Wealth Advisory LLC’s investment portfolio, making the stock its 7th biggest position. RPg Family Wealth Advisory LLC owned approximately 0.06% of Tenet Healthcare at the end of the most recent reporting period.
Several other large investors also recently modified their holdings of the stock. Blueshift Asset Management LLC acquired a new stake in Tenet Healthcare during the 3rd quarter worth approximately $1,042,000. Bridgewater Associates LP boosted its position in shares of Tenet Healthcare by 29.5% in the third quarter. Bridgewater Associates LP now owns 125,123 shares of the company’s stock valued at $20,795,000 after acquiring an additional 28,486 shares during the period. Freedom Investment Management Inc. bought a new position in Tenet Healthcare during the third quarter worth about $405,000. Cynosure Group LLC bought a new stake in Tenet Healthcare in the 3rd quarter valued at about $368,000. Finally, Townsquare Capital LLC bought a new position in shares of Tenet Healthcare during the third quarter worth approximately $384,000. 95.44% of the stock is owned by institutional investors.
Tenet Healthcare Stock Performance
NYSE THC opened at $145.64 on Wednesday. Tenet Healthcare Co. has a twelve month low of $65.90 and a twelve month high of $171.20. The stock has a fifty day simple moving average of $158.44 and a 200 day simple moving average of $148.32. The company has a market capitalization of $13.85 billion, a price-to-earnings ratio of 4.66, a PEG ratio of 0.64 and a beta of 2.15. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 2.35.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on the company. The Goldman Sachs Group increased their price target on Tenet Healthcare from $173.00 to $196.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. UBS Group upped their price objective on shares of Tenet Healthcare from $197.00 to $217.00 and gave the stock a “buy” rating in a research report on Wednesday, October 30th. Royal Bank of Canada lifted their price objective on shares of Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a research note on Wednesday, October 30th. Barclays boosted their price target on Tenet Healthcare from $171.00 to $190.00 and gave the stock an “overweight” rating in a report on Friday, November 8th. Finally, Truist Financial reissued a “buy” rating and set a $190.00 target price (up previously from $180.00) on shares of Tenet Healthcare in a research note on Wednesday, October 30th. Two equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and three have issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $168.19.
Read Our Latest Report on Tenet Healthcare
Insiders Place Their Bets
In other Tenet Healthcare news, insider R. Scott Ramsey sold 11,599 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $162.06, for a total value of $1,879,733.94. Following the sale, the insider now directly owns 6,324 shares in the company, valued at $1,024,867.44. This represents a 64.72 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Lisa Y. Foo sold 4,000 shares of the business’s stock in a transaction dated Thursday, October 31st. The stock was sold at an average price of $155.94, for a total value of $623,760.00. Following the transaction, the executive vice president now owns 15,566 shares of the company’s stock, valued at approximately $2,427,362.04. The trade was a 20.44 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 0.93% of the company’s stock.
About Tenet Healthcare
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.
Recommended Stories
- Five stocks we like better than Tenet Healthcare
- What Are Dividend Achievers? An Introduction
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is a Special Dividend?
- 2 Generic Drug Stocks Ready to Surge in 2025
- Why Are These Companies Considered Blue Chips?
- 3 Small-Cap Stocks That Are Ready to Rocket Higher
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.